$1.490
+0.096 (+6.43%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ELTX Prediction & Forecast by Similar Chart Analysis
Alphio's ELTX stock price prediction model matches the current Elicio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.49 (-0.17%). The 1-week path is $1.51 (+1.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Elicio Therapeutics Inc Stock?
Elicio Therapeutics Inc is not a good buy right now due to its current price of $1.59, a significantly low RSI of 34.022 indicating oversold conditions, and a staggering year-to-date change of -80.25%. The company is facing financial challenges, highlighted by a net income loss of $14 million in Q4 2024 and a projected EPS of -0.42 for the upcoming earnings report. The main risk is the ongoing clinical trial setbacks, which have led to a bearish sentiment among investors, as reflected in the stock's decline of over 36% this year.
ELTX stock price ended at $1.49 on Friday, after rising +6.43%
Elicio Therapeutics Inc (ELTX) last closed at $1.49, gaining +6.43%. These facts feed the 1-day and 1-week ELTX price prediction above.
Forecast Drivers
Elicio Therapeutics Inc (ELTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ELTX, ranked by similarity.
Seasonality analysis for ELTX
Historically the probability of a positive November return for ELTX is 43.18%. May offers the highest probability of a positive month at 95.24%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ELTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $6.98 | $8.97 | $10.72 | +502.22% |
| Dec 2026 | $10.58 | $11.28 | $13.43 | +656.92% |
In 2026, Elicio Therapeutics Inc (ELTX) is projected to range from $6.98 to $13.43.
Elicio Therapeutics Inc 2026 monthly forecast
In Nov 2026, Elicio Therapeutics Inc is projected to average $8.97, with a low of $6.98 and high of $10.72.
In Dec 2026, Elicio Therapeutics Inc is projected to average $11.28, with a low of $10.58 and high of $13.43.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.